Status:

COMPLETED

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients

Lead Sponsor:

Magna Pharmaceuticals, Inc.

Conditions:

Rhinitis, Allergic, Seasonal

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

Brief Summary

MAGNA intends to show that the combination of pseudoephedrine, chlorpheniramine, plus a small amount of belladonna alkaloid is a comprehensive, safe and effective twice daily (BID) drug treatment for ...

Detailed Description

No procedure will be performed until Informed Consent has been obtained. Inclusion and exclusion criteria will be verified. Subjects will be required to stop using oral nasal decongestants or first ge...

Eligibility Criteria

Inclusion

  • Males and females of any ethnic group between the ages of 18 and 60 years of age.
  • History of moderate to severe SAR for at least one year.
  • Subjects' symptoms will include the five symptoms ("S5") that are the focus of this study:
  • nasal congestion;
  • rhinorrhea;
  • nasal itching;
  • sneezing;
  • post nasal drip.
  • Prior to study subjects' good health will be confirmed by medical history and physical examination.
  • Allergic hypersensitivity will be confirmed by an appropriate test as deemed necessary by the physician or well established medical history.

Exclusion

  • Pregnancy or lactation.
  • Immunotherapy unless at stable maintenance dose.
  • Presence of a medical condition that might interfere with treatment evaluation or require a change in therapy including but not limited to high blood pressure or urinary retention problems.
  • Alcohol dependence.
  • Use of any other investigational drug in the previous month.
  • Subjects presenting with asthma requiring corticosteroid treatment.
  • Subjects with multiple drug allergies.
  • Subjects known to have an idiosyncratic reaction to any of the ingredients in STAHIST.

Key Trial Info

Start Date :

October 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT00932256

Start Date

October 1 2009

End Date

December 1 2010

Last Update

December 8 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Family Allergy and Asthma Research Institute

Louisville, Kentucky, United States, 40215